• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 909-923 of 1,261 results

2464 Exhibit: EX2464 Steglatro Prescribing Information rev Dec 2017

Document IPR2023-00724, No. 2464 Exhibit - EX2464 Steglatro Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

1159 Exhibit: Exhibit 1159 McGuire

Document IPR2023-00724, No. 1159 Exhibit - Exhibit 1159 McGuire (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

2451 Exhibit: EX2451 US Food Drug Administration, DrugsFDA, Glyxambi

Document IPR2023-00724, No. 2451 Exhibit - EX2451 US Food Drug Administration, DrugsFDA, Glyxambi (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2445 Exhibit: EX2445 Trulicity® Prescribing Information rev Aug 2017

Document IPR2023-00724, No. 2445 Exhibit - EX2445 Trulicity® Prescribing Information rev Aug 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2529 Exhibit: EX2529 Eli Lilly Co, Income Statements for Year Ending 2019 to 2022...

Document IPR2023-00724, No. 2529 Exhibit - EX2529 Eli Lilly Co, Income Statements for Year Ending 2019 to 2022, httpsinvestorlillycomfinancial informationfundamentalsincome statement, last visited ...

cite Cite Document
Analyze

2468 Exhibit: EX2468 Stegluromet Prescribing Information rev Dec 2017

Document IPR2023-00724, No. 2468 Exhibit - EX2468 Stegluromet Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

1139 Exhibit: Exhibit 1139 Lorenz

Document IPR2023-00724, No. 1139 Exhibit - Exhibit 1139 Lorenz (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1091 Exhibit: Bloodworth Declaration

Document IPR2023-00724, No. 1091 Exhibit - Bloodworth Declaration (P.T.A.B. Dec. 18, 2023)

cite Cite Document
Analyze

1074 Exhibit: WO098

Document IPR2023-00724, No. 1074 Exhibit - WO098 (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1056 Exhibit: US5118666

Document IPR2023-00724, No. 1056 Exhibit - US5118666 (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1068 Exhibit: US8129343

Document IPR2023-00724, No. 1068 Exhibit - US8129343 (P.T.A.B. Mar. 16, 2023)

cite Cite Document
Analyze

1148 Exhibit: Exhibit 1148 Yu

Document IPR2023-00724, No. 1148 Exhibit - Exhibit 1148 Yu (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

1102 Exhibit: Exhibit 1102 Rubio Herrera

Document IPR2023-00724, No. 1102 Exhibit - Exhibit 1102 Rubio Herrera (P.T.A.B. May. 22, 2024)

cite Cite Document
Analyze

2449 Exhibit: EX2449 US Food Drug Administration, DrugsFDA, Xigduo® XR

Document IPR2023-00724, No. 2449 Exhibit - EX2449 US Food Drug Administration, DrugsFDA, Xigduo® XR (P.T.A.B. Jan. 17, 2024)

cite Cite Document
Analyze

2110 Exhibit: EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SU...

Document IPR2023-00724, No. 2110 Exhibit - EX2110 Verges, B and Charbonnel, B, After the LEADER trial and SUSTAIN 6, how do we explain the cardiovascular benefits of some GLP 1 receptor agonis...

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 61 62 63 64 65 ... >>